Literature DB >> 21245408

In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations.

Qing Zhang1, Hua Yang, Shin J Kang, Yanggan Wang, Geoffrey D Wang, Tonya Coulthard, Hans E Grossniklaus.   

Abstract

PURPOSE: To evaluate the usefulness of in vivo imaging of uveal melanoma in mice using high-frequency contrast-enhanced ultrasound (HF-CE-US) with 2D or 3D modes and to correlate the sonographic findings with histopathologic characteristics.
METHODS: Fourteen 12-week-old C57BL6 mice were inoculated into their right eyes with aliquots of 5 × 10(5)/2.5 μL B16LS9 melanoma cells and were randomly assigned to either of two groups. At 7 days after inoculation, tumor-bearing eyes in group 1 (n = 8) were imaged using HF-CE-US to determine the 2D tumor size and relative blood volume; eyes in group 2 (n = 6) were imaged by 3D microbubble contrast-enhanced ultrasound, and the tumor volume was determined. Histologic tumor burden was quantified in enucleated eyes by image processing software, and microvascular density was determined by counting von Willebrand factor-positive vascular channels. Ultrasound images were evaluated and compared with histopathologic findings.
RESULTS: Using HF-CE-US, melanomas were visualized as relatively hyperechoic regions. The intraobserver variability of sonographic measurements was 9.65% ± 7.89%, and the coefficient of variation for multiple measurements was 7.33% ± 5.71%. The correlation coefficient of sonographic volume or size and histologic area was 0.71 (P = 0.11) and 0.79 (P = 0.32). The relative blood volume within the tumor demonstrated sonographically correlated significantly with histologic tumor vascularity (r = 0.83; P < 0.001).
CONCLUSIONS: There was a positive linear correlation between sonographic tumor measurements and histologic tumor burden in the mouse ocular melanoma model. Contrast-enhanced intensity corresponded with microvascular density and blood volume. HF-CE-US is a real-time, noninvasive, reliable method for in vivo evaluation of experimental intraocular melanoma tumor area and relative blood volume.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245408      PMCID: PMC3088556          DOI: 10.1167/iovs.10-6794

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  40 in total

1.  Controlled vesicle deformation and lysis by single oscillating bubbles.

Authors:  Philippe Marmottant; Sascha Hilgenfeldt
Journal:  Nature       Date:  2003-05-08       Impact factor: 49.962

2.  A new ultrasound instrument for in vivo microimaging of mice.

Authors:  F S Foster; M Y Zhang; Y Q Zhou; G Liu; J Mehi; E Cherin; K A Harasiewicz; B G Starkoski; L Zan; D A Knapik; S L Adamson
Journal:  Ultrasound Med Biol       Date:  2002-09       Impact factor: 2.998

3.  Possible use of transrectal power Doppler imaging as an indicator of microvascular density of prostate cancer.

Authors:  T Nakanouchi; K Okihara; M Kojima; O Ukimura; K Yokoyama; T Takamatsu; T Miki
Journal:  Urology       Date:  2001-10       Impact factor: 2.649

4.  Three-dimensional ultrasound for the measurement of choroidal melanomas.

Authors:  J M Romero; P T Finger; R B Rosen; R Iezzi
Journal:  Arch Ophthalmol       Date:  2001-09

5.  Prognostic factors in choroidal and ciliary body melanomas.

Authors:  H F Shammas; F C Blodi
Journal:  Arch Ophthalmol       Date:  1977-01

6.  Incidence of uveal melanoma in the United States: 1973-1997.

Authors:  Arun D Singh; Allan Topham
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

7.  Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas.

Authors:  E Richtig; G Langmann; K Müllner; G Richtig; J Smolle
Journal:  Eye (Lond)       Date:  2004-06       Impact factor: 3.775

8.  Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma.

Authors:  Wenjun Li; Evangelos S Gragoudas; Kathleen M Egan
Journal:  Arch Ophthalmol       Date:  2003-01

9.  Radiotherapy of choroidal melanoma with iodine-125.

Authors:  S Packer; M Rotman
Journal:  Ophthalmology       Date:  1980-06       Impact factor: 12.079

10.  Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases.

Authors:  Päivi Toivonen; Teemu Mäkitie; Emma Kujala; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-01       Impact factor: 4.799

View more
  14 in total

1.  Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy.

Authors:  Rod D Braun; Kerry S Vistisen
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 2.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

3.  In vivo high-frequency contrast-enhanced ultrasonography of choroidal melanoma in rabbits: imaging features and histopathologic correlations.

Authors:  Shin J Kang; Qing Zhang; Samirkumar R Patel; Damian Berezovsky; Hua Yang; Yanggan Wang; Hans E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2013-05-04       Impact factor: 4.638

4.  Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging.

Authors:  Benjamin Theek; Felix Gremse; Sijumon Kunjachan; Stanley Fokong; Robert Pola; Michal Pechar; Roel Deckers; Gert Storm; Josef Ehling; Fabian Kiessling; Twan Lammers
Journal:  J Control Release       Date:  2014-03-12       Impact factor: 9.776

5.  Combined Radiofrequency Ablation and Double Anti-Angiogenic Protein Therapy to Increase Coagulation Efficacy: An Experimental Study in a Murine Renal Carcinoma Model.

Authors:  Hong Young Jun; Jong-Hyun Ryu; Seung Jae Byun; Chang Won Jeong; Tae-Hoon Kim; Young Hwan Lee; Kwon-Ha Yoon
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

6.  Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.

Authors:  Esther A Kleibeuker; Emmanouil Fokas; Philip D Allen; Veerle Kersemans; Arjan W Griffioen; John Beech; Jaehong H Im; Sean C Smart; Kitty C Castricum; Jaap van den Berg; Iris A Schulkens; Sally A Hill; Adrian L Harris; Ben J Slotman; Henk M Verheul; Ruth J Muschel; Victor L Thijssen
Journal:  Oncotarget       Date:  2016-11-22

7.  Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth.

Authors:  Stefan Kaluz; Qing Zhang; Yuki Kuranaga; Hua Yang; Satoru Osuka; Debanjan Bhattacharya; Narra S Devi; Jiyoung Mun; Wei Wang; Ruiwen Zhang; Mark M Goodman; Hans E Grossniklaus; Erwin G Van Meir
Journal:  Oncogene       Date:  2021-07-03       Impact factor: 9.867

8.  The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.

Authors:  Hua Yang; Craig M Brackett; Vanessa Marie Morales-Tirado; Zezhong Li; Qing Zhang; Matthew W Wilson; Camille Benjamin; Wayne Harris; Edmund K Waller; Andrei V Gudkov; Lyudmila G Burdelya; Hans E Grossniklaus
Journal:  Oncotarget       Date:  2016-01-19

Review 9.  Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Authors:  Marta M Stei; Karin U Loeffler; Frank G Holz; Martina C Herwig
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

Review 10.  Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.

Authors:  Jackson R Richards; Jae Hyuk Yoo; Donghan Shin; Shannon J Odelberg
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-22       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.